Urticarial Vasculitis After First Denosumab Injection in an Osteoporotic Woman Diagnosed with Cushing’s Syndrome
Denosumab is a human-derived monoclonal immunoglobulin G2 antibody against the receptor activator of nuclear factor kappa B ligand, inhibiting the differentiation and function of osteoclast precursor cells by its antiosteoclastic action. Denosumab is approved for postmenopausal, glucocorti coid-indu...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Society of Endocrinology and Metabolism of Turkey
2022-09-01
|
| Серія: | Endocrinology Research and Practice |
| Предмети: | |
| Онлайн доступ: | https://endocrinolrespract.org/index.php/pub/article/view/1123 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|